Spinal Cord Diseases: Clinical Trials

4,026 trials for Spinal Cord Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2045 completed, 627 recruiting, 515 unknown, 236 terminated. 1662 Not applicable, 718 Phase 2, 450 Phase 1, 357 Phase 3, 141 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1662Completed 781, Recruiting 332, Unknown 210, Terminated 90, Not yet recruiting 88, Active not recruiting 76, Withdrawn 47, Enrolling by invitation 33, Suspended 5
Phase 2718Completed 406, Unknown 77, Recruiting 75, Terminated 68, Active not recruiting 31, Not yet recruiting 29, Withdrawn 24, Enrolling by invitation 4, Suspended 4
Phase 1450Completed 222, Recruiting 60, Unknown 57, Terminated 39, Not yet recruiting 27, Active not recruiting 22, Withdrawn 14, Enrolling by invitation 5, Suspended 4
Phase 3357Completed 230, Terminated 34, Unknown 26, Recruiting 23, Active not recruiting 20, Not yet recruiting 11, Withdrawn 11, Suspended 2
Phase 4141Completed 97, Unknown 20, Recruiting 7, Not yet recruiting 6, Terminated 5, Active not recruiting 4, Withdrawn 2
Early Phase 159Completed 23, Not yet recruiting 11, Recruiting 10, Unknown 5, Withdrawn 4, Active not recruiting 2, Enrolling by invitation 2, Terminated 2

Follow Spinal Cord Diseases: new trials by email Literature Review of Spinal Cord Diseases trials Research Report on Spinal Cord Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Patient-centered Assessment of the Effects of Powered Exoskeleton Use in People With Spinal Cord Injury
Rehabilitation - Spinal Cord Injuries
Not applicableSuspendedIstituto Nazionale Assicurazione contro gli Infortuni sul Lavoro182030-01-012026-03-27
A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBN
Tetramethylpyrazine nitrone (TBN) tablet / Placebo - Healthy
Phase 1Not yet recruitingGuangzhou Magpie Pharmaceuticals Co., Ltd.162028-09-012026-09-11
Device for Bladder Control for Men With SCI
Noninvasive electrical stimulation device to improve bladder control - Neurogenic Bladder
Phase 1 / Phase 2Not yet recruitingVA Office of Research and Development122028-06-012026-06-25
Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial
Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells, Placebo - Spinal Cord Injury, Safety
Phase 2Not yet recruitingXellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.602028-05-252025-11-25
Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial
testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries
Phase 2 / Phase 3Not yet recruitingVA Office of Research and Development3002027-10-012026-08-04
Evaluation of Donor-Derived B Cell Infusions in Patients With Amyotrophic Lateral Sclerosis (ALS)
B cell infusion - ALS - Amyotrophic Lateral Sclerosis
Phase 1Not yet recruitingMark Poznansky102027-09-012026-09-24
Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord Injury
Istradefylline, low oxygen therapy - Spinal Cord Injuries, Myelopathy
Phase 1 / Phase 2Not yet recruitingRandy Trumbower, PT, PhD402027-09-012026-03-20
Empowerment Program to Reduce Treatment of Asymptomatic Bacteriuria in Veterans With Spinal Cord Injury
Empowerment Program - Spinal Cord Injury, Spinal Cord Disease
Not applicableNot yet recruitingVA Office of Research and Development302027-08-022026-08-19
Cardiocentric Inotropic Optimization in Spinal Cord Injury
Dobutamine crossover - SCI - Spinal Cord Injury
Early Phase 1Not yet recruitingUniversity of British Columbia82027-06-012026-10-13
Combined rTMS and tSCS for Upper Limb Recovery in Cervical SCI
Transcranial Magnetic Stimulation, Transcutaneous Spinal Cord Stimulation - Spinal Cord Injuries (SCI)
Not applicableNot yet recruitingNational University Hospital, Singapore242027-03-302026-05-14
Safety Study of XT-150 in Participants With ALS
XT-150 - Amyotrophic Lateral Sclerosis (ALS)
Phase 1Not yet recruitingXalud Therapeutics, Inc.82027-03-012026-07-29
Xo-Motion R Exoskeleton in SCI-Adoption Study
XoMotionR- assisted locomotor training - Spinal Cord Injury
Not applicableNot yet recruitingUniversity of Alberta162027-03-012026-09-16
NeuroSuitUp: Neurorehabilitation Through Synergistic Man-machine Interfaces
Brain-Computer Interface control of robotic arms with augmented reality, Serious game with augmented reality - Spinal Cord Injuries
Not applicableEnrolling by invitationAristotle University Of Thessaloniki202027-02-012026-10-28
A Study of Single Ascending Doses of NI112 in Adults With Amyotrophic Lateral Sclerosis (ALS)
NI112, Placebo - Amyotrophic Lateral Sclerosis (ALS)
Phase 1Not yet recruitingSachi Bioworks Inc.402027-01-222026-10-30
Functional Electrical Stimulation Plus High Intensity Interval Training at Home
FES+HIIT@Home - Spinal Cord Injuries (SCI)
Not applicableNot yet recruitingUniversity Health Network, Toronto242027-01-022026-10-26
Combined TMS-tSCS for Lower Limb Rehabilitation in Chronic Incomplete SCI
Transcranial Magnetic Stimulation, Transcutaneous Spinal Cord Stimulation - Spinal Cord Injuries (SCI)
Not applicableNot yet recruitingNational University Hospital, Singapore242027-01-012026-05-19
Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
INTENT Neural Interface System - Tetraplegia/Tetraparesis, Amyotrophic Lateral Sclerosis (ALS)
Not applicableRecruitingJohns Hopkins University52027-01-012026-10-09
A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar Spine
3D-printed custom-made non-rigid biomimetic implant - Spinal Tumor
Not applicableNot yet recruitingNational Taiwan University Hospital182027-01-012025-12-17
SPX-01 Gene Therapy in Pediatric Patients With Spinal Muscular Atrophy Type 1 (RISE)
SPX-01 - Spinal Muscular Atrophy (SMA)
Early Phase 1Not yet recruitingExir Gene Pharmed12027-01-012026-10-29
Remimazolam vs Propofol for Motor and Somatosensory Evoked Potentials in Spinal Tumor Surgery
Remimazolam, Propofol - Spinal Cord Neoplasms, Spinal Neoplasms
Phase 4Not yet recruitingBeijing Tsinghua Chang Gung Hospital1902027-01-012026-10-28

Showing 20 of 4026. Sign in to see all of them.

Narrower conditions

Spinal Cord Injuries (1949)  ·  Amyotrophic Lateral Sclerosis (978)  ·  Muscular Atrophy, Spinal (280)  ·  Poliomyelitis (263)  ·  Motor Neuron Disease (161)  ·  Quadriplegia (161)  ·  Stroke (145)  ·  Diphtheria (114)  ·  Tetanus (114)  ·  Friedreich Ataxia (111)  ·  Multiple Sclerosis (110)  ·  Paraplegia (104)  ·  Spinal Cord Neoplasms (104)  ·  Spinocerebellar Ataxias (93)

Broader conditions

Central Nervous System Diseases (3996)  ·  Nervous System Diseases (3968)  ·  Wounds and Injuries (1989)  ·  Trauma, Nervous System (1946)  ·  Neuromuscular Diseases (1678)  ·  Neurodegenerative Diseases (1583)  ·  Nutritional and Metabolic Diseases (1169)  ·  Metabolic Diseases (1151)  ·  Motor Neuron Disease (1151)  ·  Proteostasis Deficiencies (978)  ·  TDP-43 Proteinopathies (973)  ·  Pathological Conditions, Signs and Symptoms (930)  ·  Signs and Symptoms (791)  ·  Neurologic Manifestations (742)

Interventions

Blood Specimen Collection (35)  ·  Exercise (32)  ·  Riluzole (31)  ·  Poliovirus Vaccine, Inactivated (28)  ·  Transcranial Direct Current Stimulation (28)  ·  nusinersen (28)  ·  diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (27)  ·  Transcranial Magnetic Stimulation (26)  ·  Surveys and Questionnaires (21)  ·  Rehabilitation (19)  ·  Risdiplam (18)  ·  Sodium Chloride (18)  ·  Physical Therapy Modalities (16)  ·  Botulinum Toxins, Type A (15)  ·  Spinal Puncture (15)

Sponsors

VA Office of Research and Development (78)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (53)  ·  University of Miami (53)  ·  GlaxoSmithKline (48)  ·  Assistance Publique - Hôpitaux de Paris (46)  ·  Shirley Ryan AbilityLab (46)  ·  Swiss Paraplegic Research, Nottwil (46)  ·  US Department of Veterans Affairs (45)  ·  Biogen (43)  ·  University of British Columbia (43)  ·  Sanofi Pasteur, a Sanofi Company (42)  ·  Kessler Foundation (40)  ·  James J. Peters Veterans Affairs Medical Center (38)  ·  Peking University Third Hospital (30)  ·  Washington University School of Medicine (30)

Countries

United States (1764)  ·  Canada (346)  ·  France (309)  ·  China (253)  ·  Italy (221)  ·  United Kingdom (205)  ·  Germany (184)  ·  Spain (173)  ·  Switzerland (148)  ·  Netherlands (126)  ·  Belgium (121)  ·  Australia (107)  ·  Turkey (Türkiye) (101)  ·  Taiwan (81)  ·  Japan (77)

Top investigators

Mark S Nash, PhD (12)  ·  William Bauman, MD (11)  ·  Merit Cudkowicz, MD (10)  ·  Jeremy Shefner, MD, PhD (8)  ·  Andrei Krassioukov, MD,PhD,FRCPC (7)  ·  Alberto Benussi, MD (6)  ·  Bjorn Oskarsson, MD (6)  ·  Edelle C Field-Fote, PT, PhD (6)

Results publications

PMID 31420846, PMID 34383289, PMID 37148485, PMID 28899825, PMID 40739200, PMID 18406958, PMID 21762873, PMID 25001669, PMID 26873055, PMID 27939059, PMID 30247091, PMID 30407030, PMID 32867698, PMID 36008843, PMID 38705943, PMID 39134021, PMID 39287519, PMID 39446982, PMID 41224659, PMID 42152086, PMID 10569435, PMID 14722039, PMID 15224087, PMID 16434671, PMID 16543552, PMID 17335974, PMID 17562928, PMID 17980667, PMID 18506712, PMID 19027233, PMID 19251627, PMID 19406289, PMID 19406290, PMID 19440247, PMID 21303266, PMID 21779958, PMID 22153001, PMID 22330108, PMID 22415951, PMID 22529995, PMID 22985379, PMID 23002086, PMID 23082850, PMID 23085704, PMID 23141478, PMID 23300829, PMID 23463272, PMID 23952636, PMID 24067398, PMID 24713270

NIH funding

2023 (27), 2025 (19), 2017 (16), 2019 (15), 2014 (11), 2018 (9), 2016 (7), 2015 (6), U01CA081457 (5), U01CA097452 (4), U54NS092091 (3), 1OT2NS136938 (2), 1OT2NS136939 (2), 2005 (2), N01NS42361 (2)